Randomized Clinical Trial Results Confirm PleuraFlow Reduces Take Back for...
Reduction in chest tube clogging and take back for bleeding shown in randomized prospective clinical trial with PleuraFlow ACT System IRVINE, CA —March 30, 2021 ClearFlow, Inc., a medical device...
View ArticlePleuraFlow Shown to Enable Improved Outcomes for Cardiac Surgery Patients in...
Reduction of Patient Complications After Heart Surgery Demonstrated with Use of the ClearFlow’s PleuraFlow ACT System Irvine, CA – October 20, 2020 — ClearFlow, Inc., a medical device company based...
View ArticleNew Published Clinical Trial Results Confirm that PleuraFlow Enables Improved...
Reduction of Patient Complications and Hospital Resource Utilization After Heart Surgery Demonstrated with Use of the PleuraFlow ACT System Irvine, CA – November 20, 2019 — ClearFlow, Inc., a medical...
View ArticleClearFlow Announces Positive Randomized Controlled Trial Results and...
Anaheim, California–May 7, 2019–ClearFlow, Inc., a medical device company based in Anaheim, California, has announced that positive clinical trial results of its PleuraFlow® device were presented at...
View ArticleClearFlow Awarded Chest Drainage Products Agreement with Premier
Anaheim, CA – August 21, 2018— ClearFlow, Inc., a medical device company based in Anaheim, California, announced today that it has been awarded a group purchasing agreement for the Chest Drainage...
View ArticleClearFlow Announces Additional Positive US Clinical Trial Results at the 2018...
Boston, MA – May 29th, 2018 — ClearFlow, Inc., a medical device company based in Anaheim, California, has announced that positive clinical trial results were presented at the National Teaching...
View ArticleNew Published Clinical Trial Results Confirm that PleuraFlow Enables Improved...
New Published Clinical Trial Results Confirm that PleuraFlow Enables Improved Quality and Cost of Care for Cardiac Surgery Patients Reduction of Patient Complications and Hospital Resource Utilization...
View ArticleClearFlow Announces Positive Randomized Controlled Trial Results and...
ClearFlow Announces Positive Randomized Controlled Trial Results and Inclusion in ERAS Guideline Recommendations Anaheim, California–May 7, 2019–ClearFlow, Inc., a medical device company based in...
View ArticleERAS Cardiac Surgery Featured at Dedicated Session at European Association...
ERAS Cardiac Surgery Featured at Dedicated Session at European Association for Cardio-Thoracic Surgery in Milan Springfield, MA — October 24, 2018 — The ERAS Cardiac Surgery Society presented its...
View ArticleClearFlow Awarded Chest Drainage Products Agreement with Premier
ClearFlow Awarded Chest Drainage Products Agreement with Premier Anaheim, CA – August 21, 2018— ClearFlow, Inc., a medical device company based in Anaheim, California, announced today that it has been...
View ArticleClearFlow Announces Additional Positive US Clinical Trial Results at the 2018...
ClearFlow Announces Additional Positive US Clinical Trial Results at the 2018 NTI Critical Care Exposition Reduction of Hospital Complications and Resource Utilization after Heart Surgery Demonstrated...
View ArticleClearFlow Reports: ERAS Cardiac Surgery Recommends Active Tube Clearance...
San Diego, California – May 2, 2018 – ClearFlow Inc. has announced that an international society of leading heart surgeons known as ERAS® Cardiac Surgery presented evidenced-based expert consensus...
View ArticleStudies Recognizing the Importance of Limiting Retained Blood to Prevent...
–ClearFlow spokespeople cite review article as latest piece of mounting evidence pertaining to urgent need for managing retained blood after surgery– Anaheim, CA – February 1, 2018—ClearFlow Inc., a...
View ArticlePeer Reviewed Study Reveals Benefits of ClearFlow’s PleuraFlow ACT System
–Study Supports Previously Published Data on Reduction of Postoperative Atrial Fibrillation After Heart Surgery Among Patients Treated with PleuraFlow Active Clearance Technology– Anaheim, CA –...
View ArticleClearFlow, Inc. Announces Positive US Clinical Trial Results
Reduction of Hospital Complications and Resource Utilization after Heart Surgery Demonstrated with Use of the PleuraFlow® ACT® System. New York City, NY – August 21, 2017 — ClearFlow, Inc., a medical...
View ArticlePleuraFlow System available for Pediatric Cardiothoracic Surgery
Anaheim, CA – July 19, 2017 — ClearFlow, Inc., a medical device company based in Anaheim, California, has announced a full market release for the 20Fr SEDL version of the PleuraFlow® Active Clearance...
View ArticleFlowGlide Technology for Cardiac Surgery Patients, Cleared by FDA
Anaheim, CA – June 20, 2017 — ClearFlow, Inc., a medical device company based in Anaheim, California, announced today that the United States Food & Drug Administration (FDA) has granted 510[k]...
View ArticleFrost & Sullivan New Product Innovation Award for PleuraFlow Technology
Anaheim, CA – April 18, 2017—ClearFlow Inc., a medical device company based in Anaheim, California, has received the prestigious 2017 Global Frost & Sullivan Award for New Product Innovation. The...
View ArticleNew Study Reveals that All Patients May be at Risk for Retained Blood after...
— ClearFlow Executives Comment on Need for New Protocols — Anaheim, CA – January 31, 2017—Clinical study results presented at the Society of Critical Care Medicine (SCCM) 46th Annual Critical Care...
View ArticleReduction in Bleeding Complications After LVAD Implantation
ClearFlow Announces New Clinical Study with Positive Results for the PleuraFlow System Anaheim, CA – November 15, 2016. ClearFlow, Inc., a medical device company based in Anaheim, California has...
View Article![BLACKPINK – DEADLINE – EP [iTunes Plus M4A]](http://is1-ssl.mzstatic.com/image/thumb/Video211/v4/de/b3/b1/deb3b1d4-ba28-22e8-2428-ef97617b2a4b/90d54d743002a6d66308f217cd867947_Preview_Image_Intermediate_nonvideo_sdr_426725135_2574858051.png/316x316bb.webp)
